June 17, 2020 / 5:02 PM / 18 days ago

BRIEF-Aspen Pharmacare Says It Owns Rights To Dexamethasone

June 17 (Reuters) - Aspen Pharmacare Holdings Ltd:

* USE OF DEXAMETHASONE IN THE CLINICAL MANAGEMENT OF PATIENTS WITH COVID-19 REQUIRING RESPIRATORY INTERVENTION

* ASPEN OWNS RIGHTS TO DEXAMETHASONE; DISTRIBUTES BOTH INJECTABLES AND/OR TABLETS CONTAINING DEXAMETHASONE IN A NUMBER OF COUNTRIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below